On Monday, U.S. markets experienced significant gains, with the S&P 500 rising 1.5% and the Nasdaq Composite climbing 2.3%, marking its first record close since June. This surge was fueled by a decline in oil prices, with West Texas Intermediate futures falling 4.5% to $95.78 a barrel, alleviating inflation concerns that had been weighing on the market.
Additionally, Treasury yields retreated from a two-decade high, as traders adjusted their expectations for further Federal Reserve tightening following last month's rate hike. The upcoming meeting between Trump and Xi is anticipated to focus on extending the trade truce established in Busan last October, although analysts suggest that substantive progress on investment frameworks may be limited.
The discussions are expected to prioritize trade over sensitive topics like Taiwan. Meanwhile, the AI sector is in the spotlight, with the U.S. government emphasizing that AI developers will be held accountable for the implications of their technologies, contrasting with OpenAI's proposal for a regulatory framework.
In the pharmaceutical sector, Eli Lilly reported a significant uptake in GLP-1 treatments among seniors since Medicare coverage began in July. Nissan is considering increasing production capacity in the U.S. without building new factories. Overall, the market's positive momentum may hinge on the outcomes of the Trump-Xi meeting, as geopolitical developments continue to shape investor sentiment